Inc.;H. Lee Moffitt Cancer Center and Research Institute
发明人:
List, Alan F.,Wei, Sheng
申请号：
AU2018205105
公开号：
AU2018205105A1
申请日:
2018.07.11
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018205105A120180726.pdf#####ABSTRACT Disclosed are compositions and methods for treating disease or condition caused or exacerbated by S100A9 activity, such as myelodysplastic syndromes (MDS) using a composition comprising an effective amount of a CD33/S100A9 inhibitor.
